Satheesh Chonat

1.9k total citations
76 papers, 889 citations indexed

About

Satheesh Chonat is a scholar working on Hematology, Physiology and Genetics. According to data from OpenAlex, Satheesh Chonat has authored 76 papers receiving a total of 889 indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Hematology, 38 papers in Physiology and 34 papers in Genetics. Recurrent topics in Satheesh Chonat's work include Erythrocyte Function and Pathophysiology (38 papers), Blood groups and transfusion (35 papers) and Hemoglobinopathies and Related Disorders (32 papers). Satheesh Chonat is often cited by papers focused on Erythrocyte Function and Pathophysiology (38 papers), Blood groups and transfusion (35 papers) and Hemoglobinopathies and Related Disorders (32 papers). Satheesh Chonat collaborates with scholars based in United States, Netherlands and United Kingdom. Satheesh Chonat's co-authors include Sean R. Stowell, Ross M. Fasano, Connie M. Arthur, Patricia E. Zerra, Jeanne E. Hendrickson, Cheryl L. Maier, Charles T. Quinn, Cassandra D. Josephson, Ryan Philip Jajosky and Seema R. Patel and has published in prestigious journals such as New England Journal of Medicine, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Satheesh Chonat

67 papers receiving 883 citations

Peers

Satheesh Chonat
Sylvia T. Singer United States
Satheesh Chonat
Citations per year, relative to Satheesh Chonat Satheesh Chonat (= 1×) peers Sylvia T. Singer

Countries citing papers authored by Satheesh Chonat

Since Specialization
Citations

This map shows the geographic impact of Satheesh Chonat's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Satheesh Chonat with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Satheesh Chonat more than expected).

Fields of papers citing papers by Satheesh Chonat

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Satheesh Chonat. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Satheesh Chonat. The network helps show where Satheesh Chonat may publish in the future.

Co-authorship network of co-authors of Satheesh Chonat

This figure shows the co-authorship network connecting the top 25 collaborators of Satheesh Chonat. A scholar is included among the top collaborators of Satheesh Chonat based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Satheesh Chonat. Satheesh Chonat is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Briones, Michael, et al.. (2025). Infection risk in pediatric complement inhibition: Insights from a single-center experience. Immunobiology. 230(4). 152934–152934.
2.
Schoettler, Michelle Long, Adrianna Westbrook, Benjamin Watkins, et al.. (2024). Age, GVHD prophylaxis, and timing matter in thrombotic microangiopathy after haematopoietic cell transplantation—A secondary CIBMTR analysis. British Journal of Haematology. 205(1). 243–255. 1 indexed citations
3.
Chonat, Satheesh, et al.. (2024). Voxelotor improves red blood cell functionality in children with sickle cell anaemia: An ancillary study of the HOPE‐KIDS 1 trial. SHILAP Revista de lepidopterología. 5(1). 125–130. 3 indexed citations
4.
Schoettler, Michelle Long, Shanmuganathan Chandrakasan, Suhag Parikh, et al.. (2024). D‐dimer and sinusoidal obstructive syndrome‐novel poor prognostic features of thrombotic microangiopathy in children after hematopoietic cellular therapy in a single institution prospective cohort study. American Journal of Hematology. 99(3). 370–379. 7 indexed citations
5.
Manci, Elizabeth A., et al.. (2024). Placental Abnormalities in the Humanized Mouse Model of Sickle Cell Disease. Blood. 144(Supplement 1). 2487–2487.
6.
Kulasekararaj, Austin, Francesco Lanza, Saskia Langemeijer, et al.. (2024). Comparative clinical efficacy and safety of biosimilar ABP 959 and eculizumab reference product in patients with paroxysmal nocturnal hemoglobinuria. American Journal of Hematology. 99(11). 2108–2117. 4 indexed citations
7.
Manci, Elizabeth A., et al.. (2023). Characterizing Pregnancy Outcomes in a Humanized Mouse Model of Sickle Cell Disease. Blood. 142(Supplement 1). 563–563.
9.
Jajosky, Ryan Philip, Kashyap Patel, Patricia E. Zerra, et al.. (2023). Antibody-mediated antigen loss switches augmented immunity to antibody-mediated immunosuppression. Blood. 142(12). 1082–1098. 17 indexed citations
10.
Schoettler, Michelle Long, Seema R. Patel, Benjamin Watkins, et al.. (2023). Compassionate Use Narsoplimab for Severe Refractory Transplantation-Associated Thrombotic Microangiopathy in Children. Transplantation and Cellular Therapy. 30(3). 336.e1–336.e8. 3 indexed citations
11.
Arthur, Connie M., Seema R. Patel, Patricia E. Zerra, et al.. (2022). Clodronate inhibits alloimmunization against distinct red blood cell alloantigens in mice. Transfusion. 62(5). 948–953. 12 indexed citations
12.
DeGroote, Nicholas P., Frank G. Keller, Katharine E. Brock, et al.. (2022). Characteristics and outcomes of pediatric oncology patients at risk for guardians declining transfusion of blood components. Cancer Reports. 6(1). e1665–e1665. 1 indexed citations
13.
Schoettler, Michelle Long, Elizabeth Stenger, Ann E. Haight, et al.. (2022). Sickle cell disease is a risk factor for transplant-associated thrombotic microangiopathy in children. Blood Advances. 7(9). 1784–1795. 9 indexed citations
14.
Arthur, Connie M., Hans Verkerke, Ryan Philip Jajosky, et al.. (2021). Antigen density dictates RBC clearance, but not antigen modulation, following incompatible RBC transfusion in mice. Blood Advances. 5(2). 527–538. 16 indexed citations
15.
Zerra, Patricia E., Seema R. Patel, Ryan Philip Jajosky, et al.. (2021). Marginal zone B cells mediate a CD4 T-cell–dependent extrafollicular antibody response following RBC transfusion in mice. Blood. 138(8). 706–721. 38 indexed citations
16.
Boscoe, Audra, Elizabeth Hedgeman, Eduard J. van Beers, et al.. (2020). Comorbidities and complications in adults with pyruvate kinase deficiency. European Journal Of Haematology. 106(4). 484–492. 17 indexed citations
17.
Josephson, Cassandra D., Hans Verkerke, W. Matthew Linam, et al.. (2020). Complement Inhibition in Severe COVID-19 Acute Respiratory Distress Syndrome. Frontiers in Pediatrics. 8. 616731–616731. 6 indexed citations
18.
Thein, Swee Lay, France Pirenne, Ross M. Fasano, et al.. (2020). Hemolytic transfusion reactions in sickle cell disease: underappreciated and potentially fatal. Haematologica. 105(3). 539–544. 47 indexed citations
19.
Lesmana, Harry, Lisa Dyer, Xia Li, et al.. (2017). Alu element insertion inPKLRgene as a novel cause of pyruvate kinase deficiency in Middle Eastern patients. Human Mutation. 39(3). 389–393. 5 indexed citations
20.
Niss, Omar, Satheesh Chonat, Neha Dagaonkar, et al.. (2016). Genotype-phenotype correlations in hereditary elliptocytosis and hereditary pyropoikilocytosis. Blood Cells Molecules and Diseases. 61. 4–9. 49 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026